Premium
Liver transplantation for non–hepatocellular carcinoma malignancies
Author(s) -
Gores Gregory J.,
Heimbach Julie K.,
Rosen Charles B.
Publication year - 2010
Publication title -
liver transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.814
H-Index - 150
eISSN - 1527-6473
pISSN - 1527-6465
DOI - 10.1002/lt.22145
Subject(s) - medicine , hepatocellular carcinoma , liver transplantation , transplantation , milan criteria , carcinoma , oncology
Key Points 1. Hepatic epithelioid hemangioendothelioma is a rare disease with a variable natural history; current data support liver transplantation for unresectable disease. 2. Anti–vascular endothelial cell growth factor therapy may change the approach to hepatic epithelioid hemangioendothelioma in the future. 3. The role of liver transplantation in the treatment of neuroendocrine tumors remains unclear; more data obtained by standardized approaches are needed for evidence‐based decision making. 4. Liver transplantation is curative in highly selected patients with perihilar cholangiocarcinoma when it is combined with neoadjuvant therapy. Liver Transpl 16:S22‐S25, 2010. © 2010 AASLD.